コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 f cross-species overlap in cancer-associated copy number aberrations.
2 profiles revealed numerous recurrent genomic copy number aberrations.
3 y modeling transformations of the genome via copy number aberrations.
4 ng of 232 LCINS showed 3 subtypes defined by copy number aberrations.
5 on as determined by somatic mutations and/or copy number aberrations.
6 mmune infiltration, high MYC expression, and copy number aberrations.
7 essential in tumor cells with high levels of copy number aberrations.
8 ion, expansive 3D growth, and high burden of copy number aberrations.
9 We also observe biases in chromosome copy number aberrations.
10 ferentially methylated regions and detecting copy number aberrations.
11 er genes are targeted by regional chromosome copy number aberrations.
12 led similar frequencies of recurrent genomic copy number aberrations.
13 few driver point mutations but abundant DNA copy number aberrations.
14 predominantly nonsilent mutations, and fewer copy number aberrations.
15 ng the statistical significance of recurrent copy number aberrations.
16 troduced for identifying common regions with copy number aberrations.
17 o distinguish between recurrent and sporadic copy number aberrations.
18 s, mutational profiles, gene expression, and copy-number aberrations.
19 omas had a significantly higher frequency of copy number aberrations (67%) than other subgroups (P =
20 .0 array-based genomic profiling of acquired copy number aberrations (aCNA) and copy neutral LOH (cnL
21 genesis of CLL as recurrent acquired genomic copy number aberrations (aCNA) and recurrent gene mutati
22 m 255 patients with CLL for acquired genomic copy number aberrations (aCNAs) with the use of ultra-hi
29 also extend SubMARine to work with subclonal copy number aberrations and define equivalence constrain
30 nitiating cells have uncovered multiple gene copy number aberrations and have yielded new insight int
31 edominant UV mutational signature, increased copy number aberrations and increased mutant TP53 select
32 We validate our GBM cohort, finding similar copy number aberrations and mutated genes based on codin
33 g, which is limited in its ability to detect copy number aberrations and other genomic changes beyond
34 relationships of protein expression with DNA copy number aberrations and signatures of post-transcrip
35 variations, small insertions and deletions, copy number aberrations and structural variations in bot
36 on a subset of genes by nucleotide variants, copy number aberrations, and gene fusions highlight the
38 novel biomarkers based on gene expressions, copy number aberrations, and mutations predictive of dru
39 omatic mutations (up to 50 bases in length), copy number aberrations, and structural rearrangements i
40 rrently mutated with coding point mutations, copy number aberrations, and their associations with pat
41 tumours were characterised by an absence of copy-number aberrations apart from LOH chromosome 16q, t
42 dual evolution, showing that the majority of copy number aberrations are acquired at the earliest sta
43 edian of 68.9% of point mutations and 83% of copy number aberrations are shared between different his
45 ic landscape of mCRC reveals a number of DNA copy number aberrations associated with response to drug
51 el approach for finding regions of recurrent copy number aberrations, called CNAnova, from Affymetrix
53 CLLs by combining whole-exome sequencing and copy number aberration (CNA) analysis, which showed an a
57 a necessitates untangling the effects of the Copy Number Aberration (CNA) occurrence rates and the se
59 nd MYD88(L265P) mutation and the genome-wide copy number aberration (CNA) profiles of individual vitr
60 ntify potential driver genes on the basis of copy number aberration (CNA) regions of cancer genomes,
61 of metastasis, and to define multichromosome copy number aberration (CNA) signatures that can be used
62 es in 2,433 primary breast tumours that have copy number aberration (CNA), gene expression and long-t
63 se approach to identify the most significant copy number aberrations (CNA) and identified regions of
65 s, we performed a genome-wide search for DNA copy number aberrations (CNA) in a panel of 33 tumors en
67 erived from breast tumours devoid of somatic copy-number aberrations (CNA-devoid) are consistently pr
70 Cancer progression is driven by both somatic copy number aberrations (CNAs) and chromatin remodeling,
72 (n = 29), for which genome-wide chromosomal copy number aberrations (CNAs) and mutational profiles f
73 ithm to simultaneously infer allele-specific copy number aberrations (CNAs) and reconstruct spatial t
77 ymorphism (SNP) arrays allows measurement of copy number aberrations (CNAs) in cancer at more than on
80 -derived from real data-that contain somatic copy number aberrations (CNAs) of various lengths and fr
81 anding the biological and clinical impact of copy number aberrations (CNAs) on the development of pre
82 cleotide polymorphisms) and acquired somatic copy number aberrations (CNAs) were associated with expr
84 humans by comparing all D. rerio genes with copy number aberrations (CNAs) with a cohort of 75 publi
87 evelopment of numerous methods for detecting copy number aberrations (CNAs), a key driver of genetic
88 ic driver single nucleotide variants (SNVs), copy number aberrations (CNAs), and structural variants
89 analyzed single nucleotide variants (SNVs), copy number aberrations (CNAs), and subclonal architectu
92 detect single nucleotide variants (SNVs) and copy number aberrations (CNAs), while MutSigCV (SNVs) an
94 tations in bona fide drivers (TP53BP1, BLM), copy number aberrations (CNAs; 1qGain, 17pLOH), and doub
95 med to assess the prognostic significance of copy-number aberrations (CNAs) and copy-neutral loss of
98 s becoming common, yet most methods to infer copy-number aberrations (CNAs) from this data analyze in
99 ve from chemorefractory disease, we examined copy-number aberrations (CNAs) in circulating tumor cell
100 s limited their use to the analysis of large copy-number aberrations (CNAs) in individual cells.
101 We identified extensive allele-specific copy-number aberrations (CNAs) in these samples, includi
104 integrated the multi-omics datasets such as copy number aberration, DNA methylation, gene and microR
105 ype, or G-CIMP tumors, have distinct genomic copy number aberrations, DNA methylation patterns, and (
106 roups of meningioma by combining DNA somatic copy-number aberrations, DNA somatic point mutations, DN
107 ofiles to identify relationships between DNA copy number aberrations, gene expression alterations, an
108 q24 and a total number of independent genome copy number aberrations >7 are associated with reduced s
109 profiling remains difficult because true DNA copy-number aberrations have to be discriminated from WG
110 t cancer-specific survival (METABRIC cohort [copy number aberration]: hazard ratio [HR] 1.50, 95% CI
112 to investigate the prevalence of chromosomal copy number aberrations in 256 products of conception (P
113 eletions of 360 cancer genes and genome-wide copy number aberrations in 413 and 170 ILBC samples, res
114 ll variants were present in 94% of cases and copy number aberrations in at least one gene in 58% of c
115 We studied 282 females with SBC, focusing on copy number aberrations in cancer-free breast tissue (un
116 sistent with previous studies, such as large copy number aberrations in chromosome 8 and complex rear
117 enomic hybridization to identify and compare copy number aberrations in five mouse models of breast c
119 to increased genome instability and genomic copy number aberrations in genes implicated in EGFR TKI
120 at molecular subtypes are linked to specific copy number aberrations in genes such as mutant KRAS and
122 that triple-negative breast cancers acquire copy number aberrations in short punctuated bursts in th
124 allows quantitative detection and mapping of copy number aberrations in tumors and subsequent associa
126 arrays, we conducted an analysis of somatic copy-number aberrations in 486 gastrointestinal adenocar
127 overy of differentially amplified or deleted copy-number aberrations in a case group of cancer compar
128 verely retarded patients, were found to have copy-number aberrations in addition to the 5p deletion.
129 asis by identifying genes with more frequent copy-number aberrations in BM-LUAD compared to 503 prima
131 progression identified are TP53 mutation and copy number aberrations, including a notable amplicon on
133 me is represented by an integer vector and a copy number aberration is an event that either increases
136 ifferent molecular events, including somatic copy number aberration, may be a common characteristic o
137 clinicopathological relevance of SPAG5 gene copy number aberrations, mRNA transcript expression, and
138 comparative genomic hybridization to analyse copy number aberrations occurring in FTC in order to obt
140 syndrome (TS) and Klinefelter syndrome (KS) copy number aberrations of the X chromosome lead to vari
143 current single nucleotide variants and focal copy number aberrations, poor-prognosis hindbrain ependy
145 University Hospital to identify genome-wide copy number aberrations, putative driver genes, deregula
146 olution across the genome to map genomic DNA copy number aberrations quantitatively from 14 FTC onto
147 ion sites were enriched in recurrent somatic copy-number aberration regions from multiple cancer type
149 sed by a large number of somatic chromosomal copy number aberrations (SCNA) that frequently affect on
151 visualization of complex patterns of somatic copy number aberrations (SCNAs) and structural variants
152 omatic structural variants (SVs) and somatic copy number aberrations (SCNAs) is critical to study the
153 rmal melanocytic proliferations that exhibit copy number aberrations should undergo careful clinical
154 eomic data illuminated biology downstream of copy number aberrations, somatic mutations, and fusions
155 without chronic sun-induced damage) for DNA copy number aberrations specific to melanoma subtypes wh
156 some breaks, inversions, deletions and micro copy number aberrations, specifically in BRCA1-deficient
157 cleotide variants, insertions and deletions, copy-number aberrations, structural variants and gene fu
158 that contain the 17q23 amplicon, a recurrent copy number aberration that defines about 9% of all prim
159 ssion and analysed the associations of SPAG5 copy number aberrations, transcript expression, and prot
161 6 esophageal adenocarcinoma was analyzed for copy number aberrations using Affymetrix SNP 6.0 arrays.